Skip to main content
Premium Trial:

Request an Annual Quote

Moving Around

Roche announced that Pascal Soriot will be taking over as head of the company's pharma division when Bill Burns steps down at the end of the year, according to the Wall Street Journal's Health Blog. According to Roche, Soriot joined the company from Sanofi-Aventis and oversaw the Genentech integration. The Health Blog says Soriot "has big shoes to fill. Burns led a long period of growth at the pharma division, and has been a favorite with analysts and investors, who say they appreciate his straightforward manner and wit."

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.